{"meta":{"query_hash":"d4a1c087bc78","filters":{"venue":"UroOncology"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d4a1c087bc78","api":"https://metacan.xera.ac/api/v1/cohort?venue=UroOncology"},"results":[{"id":"W2028878554","doi":"10.1080/1561095021000072227","title":"Determinants of Accrual to Prostate Cancer Clinical Trials","year":2002,"lang":"en","type":"article","venue":"UroOncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Accrual; Medicine; Clinical trial; Prostate cancer; Family medicine; Cancer; Alternative medicine; Internal medicine; Finance; Pathology","score_opus":0.8569149178022224,"score_gpt":0.738032482667811,"score_spread":0.11888243513441143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028878554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9343463,0.0069835554,0.009708753,0.026937868,0.00019102897,0.0026760276,0.00039556573,0.0001008094,0.018660033],"genre_scores_gemma":[0.9952251,0.000551316,0.002207181,0.00088169385,0.00010520957,0.0004230018,0.000094226176,0.000017891074,0.00049439847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.7501131,0.20403793,0.013149804,0.0044646827,0.021527791,0.006706608],"domain_scores_gemma":[0.34424165,0.50140536,0.09535042,0.018975161,0.022292502,0.017734876],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.20047894,0.00027132765,0.00067442155,0.0020847814,0.0021379762,0.0041346024,0.0016146002,0.0016818807,0.00414764],"category_scores_gemma":[0.5428338,0.00036656178,0.00070814224,0.002104996,0.0028777968,0.0023105224,0.0034222538,0.0031266566,0.0006657436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012620032,0.00055747817,0.901537,0.00024516854,0.00015533649,0.00018813543,0.0032676095,0.0007933467,0.00023422831,0.0046936,0.0031280757,0.08393811],"study_design_scores_gemma":[0.00036990474,0.001611472,0.9595054,0.00067967735,0.00021024041,0.0011404152,0.0034476875,0.0052299453,0.00092022715,0.009608467,0.017210586,0.00006598344],"about_ca_topic_score_codex":0.0055365614,"about_ca_topic_score_gemma":0.00416413,"teacher_disagreement_score":0.20047894,"about_ca_system_score_codex":0.003624808,"about_ca_system_score_gemma":0.013088544,"threshold_uncertainty_score":0.9859518},"labels":[],"label_agreement":null}]}